(Press-News.org) Contact information: Sandy Van
sandy@prpacific.com
808-526-1708
Cedars-Sinai Medical Center
Cedars-Sinai researchers target cancer stem cells in malignant brain tumors
Approach aims to prevent brain cancer recurrence by attacking tumors at the source
LOS ANGELES (Jan. 6, 2014) – Researchers at the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Department of Neurosurgery identified immune system targets on cancer stem cells – cells from which malignant brain tumors are believed to originate and regenerate – and created an experimental vaccine to attack them.
Results of laboratory and animal studies are published in the online edition of Stem Cells Translational Medicine, and will appear in the March 2014 print edition. A Phase I safety study in human volunteers with recurrent glioblastoma multiforme, the most common and aggressive brain tumor in adults, is underway.
Like normal stem cells, cancer stem cells have the ability to self-renew and generate new cells, but instead of producing healthy cells, they create cancer cells. In theory, if the cancer stem cells can be destroyed, a tumor may not be able to sustain itself, but if the cancer originators are not removed or destroyed, a tumor will continue to return despite the use of existing cancer-killing therapies.
The researchers identified certain fragments of a protein – CD133 – that is found on cancer stem cells of some brain tumors and other cancers. In the laboratory, they cultured the proteins with dendritic cells, the immune system's most powerful antigen-presenting cells, which are responsible for helping the immune system recognize and attack invaders.
Studies in lab mice showed that the resulting vaccine was able to stimulate an immune response against the CD133 proteins without causing side effects such as an autoimmune reaction against normal cells or organs.
"CD133 is one of several proteins made at high levels in the cancer stem cells of glioblastoma multiforme. Because this protein appears to be associated with resistance of the cancer stem cells to treatment with radiation or chemotherapy or both, we see it as an ideal target for immunotherapy. We have found at least two fragments of the protein that can be targeted to trigger an immune response to kill tumor cells. We don't know yet if the response would be strong enough to prevent a tumor from coming back, but we now have a human clinical trial underway to assess safety for further study," said John Yu, MD, vice chair of the Department of Neurosurgery, director of surgical neuro-oncology, medical director of the Brain Tumor Center and neurosurgical director of the Gamma Knife Program at Cedars-Sinai. He is senior author of the journal article.
With standard care, which includes surgery, radiation treatment and chemotherapy, median length of survival is 15 months for patients diagnosed with glioblastoma multiforme. Cedars-Sinai researchers have studied dendritic cell immunotherapy since 1997, with the first patient human clinical trial launched in 1998.
###
The dendritic cell vaccines are produced by the biotechnology company ImmunoCellular Therapeutics Ltd., which funded this study. Cedars-Sinai owns equity in the company, and certain rights in the vaccine technology and corresponding intellectual property have been exclusively licensed by Cedars-Sinai to ImmunoCellular Therapeutics.
Two members of the research team and authors of this article have ties to the company. Yu, senior author, owns stock in the company and is its founder, chief scientific officer and chair of the board of directors. James Bender, PhD, MPH, a co-author, is ImmunoCellular Therapeutics' vice president for product development and manufacturing.
Researchers from Torrey Pines Institute for Molecular Studies also participated in the study.
Citation: Stem Cells Translational Medicine, "Identification of novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitopes on CD133 for cancer stem cell immunotherapy," Available online 12/27/13. To appear in the March, 2014, print edition.
http://stemcellstm.alphamedpress.org/content/early/2013/12/27/sctm.2013-0135.1.abstract
Cedars-Sinai researchers target cancer stem cells in malignant brain tumors
Approach aims to prevent brain cancer recurrence by attacking tumors at the source
2014-01-06
ELSE PRESS RELEASES FROM THIS DATE:
Yeast's lifestyle couples mating with meiosis
2014-01-06
Yeast's lifestyle couples mating with meiosis
PROVIDENCE, R.I. [Brown University] — From a biological point of view, the world's most exotic sex lives may be the ones lived by fungi. As a kingdom, they are full of surprises, and a new one reported in the journal ...
Supervolcano eruptions are triggered by melt buoyancy
2014-01-06
Supervolcano eruptions are triggered by melt buoyancy
Jointly issued by ETH Zurich, ESRF and CNRS
Supervolcanos are not usual volcanos. By effectively "exploding" as opposed to erupting, they leave a giant hole in the Earth's crust instead of a volcanic cone – a caldera, ...
Pulsar in stellar triple system makes unique gravitational laboratory
2014-01-06
Pulsar in stellar triple system makes unique gravitational laboratory
Neutron star, 2 white dwarfs give best opportunity yet to study complex gravitational interactions and may give clue to true nature of gravity
Astronomers using the National Science Foundation's ...
Ground-breaking work sheds new light on volcanic activity
2014-01-06
Ground-breaking work sheds new light on volcanic activity
Factors determining the frequency and magnitude of volcanic phenomena have been uncovered by an international team of researchers.
Experts from the Universities of Geneva, Bristol and Savoie ...
Population stability 'hope' in species' response to climate change
2014-01-06
Population stability 'hope' in species' response to climate change
Stable population trends are a prerequisite for species' range expansion, according to new research led by scientists at the University of York.
The climate in Britain has warmed over the last ...
After a 49-million-year hiatus, a cockroach reappears in North America
2014-01-06
After a 49-million-year hiatus, a cockroach reappears in North America
The cockroach in the genus Ectobius is a major textbook example of an invasive organism, and it is the most common cockroach inhabiting a large region from northernmost Europe to ...
Mine landslide triggered quakes
2014-01-06
Mine landslide triggered quakes
Record-breaking slide would bury Central Park 66 feet deep
SALT LAKE CITY, Jan. 6, 2014 – Last year's gigantic landslide at a Utah copper mine probably was the biggest nonvolcanic slide in North America's modern history, and included two ...
Self-driving vehicles offer potential benefits, policy challenges for lawmakers
2014-01-06
Self-driving vehicles offer potential benefits, policy challenges for lawmakers
Self-driving vehicles offer the promise of significant benefits to society, but raise several policy challenges, including the need to update insurance liability regulations and privacy concerns ...
Study: Half of black males, 40 percent of white males arrested by age 23
2014-01-06
Study: Half of black males, 40 percent of white males arrested by age 23
First contemporary findings on how the risk of arrest varies across race and gender
Nearly half of black males and almost 40 percent of white males in the U.S. are arrested by age 23, ...
New study may aid rearing of stink bugs for biological control
2014-01-05
New study may aid rearing of stink bugs for biological control
Many people think of stink bugs as pests, especially as the brown marmorated stink bugs spreads throughout the U.S. However, certain stink bugs are beneficial, such as Podisus nigrispinus ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Cedars-Sinai researchers target cancer stem cells in malignant brain tumorsApproach aims to prevent brain cancer recurrence by attacking tumors at the source